Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sara Horie

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Cancer Medicine|January 18, 2026
Plasma Fibrinogen Predicts Response to Immune Checkpoint Inhibitor by Inflammatory Tumor Microenvironment in Esophageal CancerKeiso Ho, Satoru Matsuda, Eisuke Booka, et al.
Oncology Letters|October 11, 2024
Clinical characteristics of gastrointestinal stromal tumors with hypoglycemiaAkihiko Chida, Kenta Kawasaki, Junko Kuramoto, et al.
Leukemia|May 2, 2025
TP53 and CDKN2A alterations define a poor prognostic subgroup in patients with nodal T follicular helper cell lymphomaYuta Ito, Joji Shimono, Keisuke Kawamoto, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Cancer Medicine|January 18, 2026
Plasma Fibrinogen Predicts Response to Immune Checkpoint Inhibitor by Inflammatory Tumor Microenvironment in Esophageal CancerKeiso Ho, Satoru Matsuda, Eisuke Booka, et al.
Oncology Letters|October 11, 2024
Clinical characteristics of gastrointestinal stromal tumors with hypoglycemiaAkihiko Chida, Kenta Kawasaki, Junko Kuramoto, et al.
Leukemia|May 2, 2025
TP53 and CDKN2A alterations define a poor prognostic subgroup in patients with nodal T follicular helper cell lymphomaYuta Ito, Joji Shimono, Keisuke Kawamoto, et al.
Pageof 2